WWM
ITCI

Wolff Wiese Magana’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Wolff Wiese Magana’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32
Closed -$4.22K – 1054
2025
Q1 		$4.22K Hold
32
– – ﹤0.01% 605
2024
Q4 		$2.67K Hold
32
– – ﹤0.01% 658
2024
Q3 		$2.34K Buy
+32
New +$2.4K ﹤0.01% 711

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolff Wiese Magana's ITCI Position: Q2 2025 in Review

Wolff Wiese Magana sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 32 shares — an estimated $4.22K sold.

Wolff Wiese Magana first reported a position in ITCI in Q3 2024 and held it in 3 quarters. The position peaked at $4.22K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Wolff Wiese Magana reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Wolff Wiese Magana sold 32 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $4.22K.
  • Wolff Wiese Magana first reported a position in Intra-Cellular Therapies Inc. in Q3 2024 and held it in 3 quarters.
  • Wolff Wiese Magana's Intra-Cellular Therapies Inc. position peaked at $4.22K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Wolff Wiese Magana's 13F filing for Q2 2025, filed 17 Jul 2025.